170 related articles for article (PubMed ID: 20037446)
21. A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer.
Saito K; Isayama H; Sakamoto Y; Nakai Y; Ishigaki K; Tanaka M; Watadani T; Arita J; Takahara N; Mizuno S; Kogure H; Ijichi H; Tateishi K; Tada M; Hasegawa K; Fukayama M; Kokudo N; Koike K
Med Oncol; 2018 May; 35(7):100. PubMed ID: 29846849
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.
Yamauchi J; Kanai M; Matsumoto S; Nishimura T; Yazumi S; Kami K; Kawaguchi Y; Yasuda H; Kitano T; Misawa A; Ishiguro H; Yoshikawa K; Yanagihara K; Fukushima M; Doi R; Chiba T
Pancreas; 2008 Apr; 36(3):327-8. PubMed ID: 18362852
[No Abstract] [Full Text] [Related]
23. A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer.
Ueno H; Okusaka T; Ikeda M; Ishiguro Y; Morizane C; Matsubara J; Furuse J; Ishii H; Nagase M; Nakachi K
Oncology; 2005; 69(5):421-7. PubMed ID: 16319514
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakagawa N; Ohge H; Sueda T
Am J Surg; 2008 Jun; 195(6):757-62. PubMed ID: 18367131
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer.
Sudo K; Hara R; Nakamura K; Kita E; Tsujimoto A; Yamaguchi T
Cancer Chemother Pharmacol; 2017 Jul; 80(1):195-202. PubMed ID: 28597040
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Uesaka K; Boku N; Fukutomi A; Okamura Y; Konishi M; Matsumoto I; Kaneoka Y; Shimizu Y; Nakamori S; Sakamoto H; Morinaga S; Kainuma O; Imai K; Sata N; Hishinuma S; Ojima H; Yamaguchi R; Hirano S; Sudo T; Ohashi Y;
Lancet; 2016 Jul; 388(10041):248-57. PubMed ID: 27265347
[TBL] [Abstract][Full Text] [Related]
27. [Long-Term Survival Due to Combination Therapy in a Patient with Locally Advanced Body-Tail Pancreatic Cancer].
Ueda N; Fujii Y; Miura S; Fujita J; Tomita Y; Ohnishi T; Fujita H; Kinami S; Omote K; Nakano Y; Kosaka T; Motoo Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1373-1375. PubMed ID: 29394638
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
[TBL] [Abstract][Full Text] [Related]
29. [A Case of Pancreatic Head Cancer Treated with Pancreaticoduodenectomy Combined with Hepatic Artery Resection Following Neoadjuvant Chemotherapy].
Maeda S; Takano S; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Kagawa S; Miyazaki M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2370-2. PubMed ID: 26805367
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
J Surg Oncol; 2012 Aug; 106(2):174-80. PubMed ID: 22331838
[TBL] [Abstract][Full Text] [Related]
31. [A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].
Okada T; Sakurai N; Yamamoto K; Motoi F; Kakizaki Y; Tamura G; Unno M; Iizawa H
Gan To Kagaku Ryoho; 2012 Jan; 39(1):135-7. PubMed ID: 22241369
[TBL] [Abstract][Full Text] [Related]
32. [The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy].
Imamura T; Ikoma H; Morimura R; Hatakeyama T; Kosuga T; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2379-81. PubMed ID: 26805370
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of normalization of serum tumor markers following neoadjuvant chemotherapy in patients with borderline resectable pancreatic carcinoma with arterial contact.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakagawa N; Okada K; Takahashi S; Sueda T
Cancer Chemother Pharmacol; 2017 Apr; 79(4):801-811. PubMed ID: 28314992
[TBL] [Abstract][Full Text] [Related]
34. Biweekly gemcitabine plus S-1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study.
Wada K; Sano K; Amano H; Miura F; Toyota N; Ito H; Shibuya M; Ikeda Y; Kainuma M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):692-8. PubMed ID: 26136371
[TBL] [Abstract][Full Text] [Related]
35. Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors.
Masui T; Doi R; Kawaguchi Y; Sato A; Nakano K; Ito T; Anazawa T; Takaori K; Uemoto S
Surg Today; 2016 Nov; 46(11):1282-9. PubMed ID: 26860274
[TBL] [Abstract][Full Text] [Related]
36. [A case of pancreatic cancer with celiac trunk and common hepatic artery invasion successfully resected after gemcitabine+S-1therapy].
Katoh R; Takeyoshi I; Sunose Y; Yoshinari D; Totsuka O; Toya H; Ogawa H; Hirai K
Gan To Kagaku Ryoho; 2012 Feb; 39(2):273-5. PubMed ID: 22333642
[TBL] [Abstract][Full Text] [Related]
37. A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer.
Kobayashi S; Honda G; Kurata M; Okuda Y; Sakamoto K; Karasawa K; Chang T; Egawa N; Kamisawa T; Omuro Y; Tsuruta K
Hepatogastroenterology; 2015 Jun; 62(140):1031-6. PubMed ID: 26902051
[TBL] [Abstract][Full Text] [Related]
38. [A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
Nakayama A; Tajima H; Kitagawa H; Shoji M; Nakanuma S; Makino I; Hayashi H; Nakagawara H; Miyashita T; Takamura H; Ohta T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2205-7. PubMed ID: 25731471
[TBL] [Abstract][Full Text] [Related]
39. [A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].
Yoshida Y; Sugawara N; Minami T; Iwata N; Ikeda K; Endoh T; Sasano H
Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):660-8. PubMed ID: 23558130
[TBL] [Abstract][Full Text] [Related]
40. [Current status and future directions of chemotherapy for pancreatic cancer].
Furuse J
Nihon Shokakibyo Gakkai Zasshi; 2013 Dec; 110(12):2060-5. PubMed ID: 24305093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
